Smith & Nephew plc

LSE SN.L

Smith & Nephew plc Total Non-Current Liabilities for the year ending December 31, 2023: USD 2.50 B

Smith & Nephew plc Total Non-Current Liabilities is USD 2.50 B for the year ending December 31, 2023, a -16.48% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • Smith & Nephew plc Total Non-Current Liabilities for the year ending December 31, 2022 was USD 2.99 B, a -7.11% change year over year.
  • Smith & Nephew plc Total Non-Current Liabilities for the year ending December 31, 2021 was USD 3.22 B, a -20.37% change year over year.
  • Smith & Nephew plc Total Non-Current Liabilities for the year ending December 31, 2020 was USD 4.04 B, a 55.94% change year over year.
  • Smith & Nephew plc Total Non-Current Liabilities for the year ending December 31, 2019 was USD 2.59 B, a 50.81% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
SV Wall Street
LSE: SN.L

Smith & Nephew plc

CEO Dr. Deepak S. Nath Ph.D.
IPO Date July 1, 1988
Location United Kingdom
Headquarters Building 5
Employees 18,000
Sector Healthcare
Industries
Description

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Similar companies

WPP.L

WPP plc

USD 9.54

-0.45%

REL.L

RELX Plc

USD 49.96

0.18%

SGE.L

The Sage Group plc

USD 16.60

-0.59%

SMIN.L

Smiths Group plc

USD 25.30

-1.17%

CPG.L

Compass Group PLC

USD 34.89

0.88%

StockViz Staff

February 4, 2025

Any question? Send us an email